Controlled
self-assembly of small molecule gadolinium (Gd) complexes
into nanoparticles (GdNPs) is emerging as an effective approach to
design activatable magnetic resonance imaging (MRI) probes and amplify
the r1 relaxivity. Herein, we employ a
reduction-controlled macrocyclization reaction and self-assembly to
develop a redox activated Gd-based MRI probe for sensing a reducing
environment. Upon disulfide reduction at physiological conditions,
an acyclic contrast agent 1 containing dual Gd-chelates
undergoes intramolecular macrocyclization to form rigid and hydrophobic
macrocycles, which subsequently self-assemble into GdNPs, resulting
in a ∼60% increase in r1 relaxivity
at 0.5 T. Probe 1 has high r1 relaxivity (up to 34.2 mM–1 s–1 per molecule at 0.5 T) upon activation, and also shows a high sensitivity
and specificity for MR detection of thiol-containing biomolecules.